D. E. Shaw & Co. Inc. decreased its stake in Hyliion Holdings Corp. (NYSE:HYLN - Free Report) by 14.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,949,691 shares of the company's stock after selling 511,755 shares during the period. D. E. Shaw & Co. Inc. owned 1.70% of Hyliion worth $7,699,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Barclays PLC raised its stake in shares of Hyliion by 272.1% in the third quarter. Barclays PLC now owns 184,685 shares of the company's stock valued at $459,000 after buying an additional 135,055 shares during the period. SG Americas Securities LLC increased its holdings in Hyliion by 118.9% in the 4th quarter. SG Americas Securities LLC now owns 57,814 shares of the company's stock worth $151,000 after acquiring an additional 31,408 shares during the last quarter. Rhumbline Advisers raised its stake in Hyliion by 4.3% in the 4th quarter. Rhumbline Advisers now owns 219,617 shares of the company's stock valued at $573,000 after acquiring an additional 8,979 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of Hyliion by 0.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,065,720 shares of the company's stock worth $2,782,000 after purchasing an additional 8,326 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Hyliion in the fourth quarter valued at approximately $43,000. 22.81% of the stock is currently owned by hedge funds and other institutional investors.
Hyliion Stock Up 2.0%
HYLN traded up $0.03 on Wednesday, hitting $1.29. The company's stock had a trading volume of 27,604,318 shares, compared to its average volume of 1,095,866. The company's 50 day simple moving average is $1.49 and its 200-day simple moving average is $2.15. Hyliion Holdings Corp. has a 12 month low of $1.17 and a 12 month high of $4.10. The firm has a market cap of $224.64 million, a P/E ratio of -3.47 and a beta of 2.76.
About Hyliion
(
Free Report)
Recommended Stories
Before you consider Hyliion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyliion wasn't on the list.
While Hyliion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
